Skip to content
AI IntelligenceJun 19, 2026Secondary Market
Article

RXRX

Recursion Pharmaceuticals filed an 8-K regarding the submission of matters to a vote of security holders. This is a routine disclosure following the annual meeting.

Data Cube AI EditorialSource: SEC EDGAR
01

Source Brief

Recursion Pharmaceuticals filed an 8-K regarding the submission of matters to a vote of security holders. This is a routine disclosure following the annual meeting.